Johnny Hilton Burns Sr, PD - Pharmacist in Marion, AR

Johnny Hilton Burns Sr, PD is a Pharmacist based in Marion, Arkansas. Johnny Hilton Burns Sr is licensed to practice in Arkansas (license number 4976) and his current practice location is 134 Block St, Marion, Arkansas. He can be reached at his office (for appointments etc.) via phone at (870) 739-4400.

NPI number for Johnny Hilton Burns Sr is 1104957018 and his current mailing address is 134 Block St, Marion, Arkansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1104957018.

Contact Information

Johnny Hilton Burns Sr, PD
134 Block St,
Marion, AR 72364-1956
(870) 739-4400
Not Available

Healthcare Provider's Profile

Full NameJohnny Hilton Burns Sr
GenderMale
SpecialityPharmacist
Location134 Block St, Marion, Arkansas
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1104957018
  • Provider Enumeration Date: 03/09/2007
  • Last Update Date: 07/09/2007

Medical Identifiers

Medical identifiers for Johnny Hilton Burns Sr such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1104957018NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 4976 (Arkansas)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Johnny Hilton Burns Sr is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Johnny Hilton Burns Sr, PD
134 Block St,
Marion, AR 72364-1956

Ph: (870) 739-4400
Johnny Hilton Burns Sr, PD
134 Block St,
Marion, AR 72364-1956

Ph: (870) 739-4400

News Archive

Radiation plus chemo quadruples survival time for fatal brain cancer

Over four times as many patients with a rapidly fatal type of brain cancer, glioblastoma multiforme (GBM), who are treated with the chemotherapy drug temozolomide (TMZ) and radiation therapy, can live for four years after diagnosis, compared to those who receive only radiation treatment, according to updated results of a large, international trial presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

Research opens potential new avenue for cancer treatment

Scientists at The University of Texas MD Anderson who identified a protein's dual role in cancer promotion have discovered a way to shut it down, opening a potential new avenue for cancer treatment.

'Fuzzy logic' alarm system may help NICU nurses predict catheter infusion failure

A "fuzzy logic" alarm system may help nurses in the neonatal intensive care unit (NICU) predict impending catheter infusion failure – and prevent complications in critically ill newborns, reports a study in the October issue of Advances in Neonatal Care, official journal of the National Association of Neonatal Nurses.

Nature News examines how scientists, farmers are working to meet the growing demand for artemisinin

"From bust to boom to bust again: artemisinin, the key ingredient of front-line antimalarial drugs, is entering the third chapter of its turbulent history," Nature News writes in an article that examines the challenges scientists and farmers are facing as they attempt to keep up with the growing demand for the compound just as a "$343-million initiative starts to battle malaria through hugely subsidized medicines."

UNC researchers identify how class of antiviral drugs interacts with HCV

Globally, an estimated 71 million people are living with chronic hepatitis C virus (HCV). Over decades of infection, chronic HCV infection results in progressive damage to the liver and an increased risk for end stage liver disease and liver cancer, making the virus the leading cause of liver-related deaths in the United States today.

Read more News

› Verified 7 days ago


Pharmacist in Marion, AR

Holley Whited, PHARM D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2695 Highway 77, Marion, AR 72364
Phone: 870-739-5518    
Mrs. Suzanne Burns Degan, PHARM D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 132 Block St, Marion, AR 72364
Phone: 870-739-4400    
Dr. Laura Charlton, PHARM. D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 134 Block St, Marion, AR 72364
Phone: 870-739-1111    Fax: 870-739-1116
Ngoc Nguyen,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2100 State Highway 77, Marion, AR 72364
Phone: 870-394-7305    
Dr. Ashley Pham, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2100 State Highway 77, Marion, AR 72364
Phone: 870-394-7305    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.